Regulation of Human CD27+IgM+B Cell Activation by Cis-Binding of the Inhibitory Molecule CD22 to CD22 Ligand (CD22L)

被引：1
|
作者：
Dijke, Esme [1 ,2 ]
Derkatz, Kim [1 ,2 ]
Pearcey, Jean [1 ,2 ]
Wong, Fred [1 ,2 ]
Motyka, Bruce [1 ,2 ]
West, Lori [1 ,2 ]
机构：
[1] Univ Alberta, Pediat, Edmonton, AB, Canada
[2] Univ Alberta, Alberta Transplant Inst, Edmonton, AB, Canada
来源：
TRANSPLANTATION | 2017年 / 101卷 / 05期
关键词：
D O I：
10.1097/01.tp.0000520297.36145.fc
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
115.5
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [21] Synthesis of Polyvalent Heterobifunctional Ligand for Redirecting IgM to Siglec CD22
    Cui, Lina
    Kitov, Pavel I.
    Completo, Gladys C.
    Paulson, James C.
    Bundle, David R.
    GLYCOBIOLOGY, 2008, 18 (11) : 999 - 999
  • [22] Cullin 3 Is Crucial for Pro-B Cell Proliferation, Interacts with CD22, and Controls CD22 Internalization on B Cells
    Meyer, Sarah J.
    Boser, Alexander
    Korn, Marina A.
    Koller, Claudia
    Bertocci, Barbara
    Reimann, Lena
    Warscheid, Bettina
    Nitschke, Lars
    JOURNAL OF IMMUNOLOGY, 2020, 204 (12) : 3360 - 3374
  • [23] TYROSINE PHOSPHORYLATION OF CD22 DURING B-CELL ACTIVATION
    SCHULTE, RJ
    CAMPBELL, MA
    FISCHER, WH
    SEFTON, BM
    SCIENCE, 1992, 258 (5084) : 1001 - 1004
  • [24] IN VIVO EFFECTS OF EPRATUZUMAB, A MONOCLONAL ANTIBODY TARGETING HUMAN CD22, ON B CELL FUNCTION IN HUMAN CD22 KNOCK-IN (HUKI) MICE
    Brandl, C.
    Oezgoer, L.
    Woehner, M.
    Shock, A.
    Nitschke, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 811 - 811
  • [25] In Vivo Effects of Epratuzumab, a Monoclonal Antibody Targeting Human CD22, on B Cell Function in Human CD22 Knock-in (Huki) Mice
    Brandl, Carolin
    Oezgoer, Lamia
    Woehner, Miriam
    Shock, Anthony
    Nitschke, Lars
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S855 - S856
  • [26] Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis
    Zhang, M
    Varki, A
    GLYCOBIOLOGY, 2004, 14 (11) : 939 - 949
  • [27] Identification of the gene variations in human CD22
    Yoko Hatta
    N. Tsuchiya
    Masaki Matsushita
    Michiko Shiota
    Kiyofumi Hagiwara
    Katsushi Tokunaga
    Immunogenetics, 1999, 49 : 280 - 286
  • [28] Identification of the gene variations in human CD22
    Hatta, Y
    Tsuchiya, N
    Matsushita, M
    Shiota, M
    Hagiwara, K
    Tokunaga, K
    IMMUNOGENETICS, 1999, 49 (04) : 280 - 286
  • [29] Expression of the B cell inhibitory molecule CD22 in patients with systemic lupus erythematosus.
    Liossis, SNC
    Dimopoulos, MA
    Sfikakis, PP
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S55 - S55
  • [30] Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding
    Nitschke, L
    Lajaunias, F
    Moll, T
    Ho, L
    Martinez-Soria, E
    Kikuchi, S
    Santiago-Raber, ML
    Dix, C
    Parkhouse, RME
    Izui, S
    INTERNATIONAL IMMUNOLOGY, 2006, 18 (01) : 59 - 68
12345